Brugia malayi Antigen (BmA) Inhibits HIV-1 Trans-Infection but Neither BmA nor ES-62 Alter HIV-1 Infectivity of DC Induced CD4⁺ Th-Cells

• Emily E. I. M. Mouser,

  Affiliation Laboratory of Experimental Virology, Department of Medical Microbiology, Centre for Infection and Immunity Amsterdam (CINIMA), Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands

  ⨯
• Georgios Pollakis,

  Affiliations Laboratory of Experimental Virology, Department of Medical Microbiology, Centre for Infection and Immunity Amsterdam (CINIMA), Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands, Department of Clinical Infection, Microbiology and Immunology (CIMI), Institute of Infection and Global Health, University of Liverpool, Liverpool, United Kingdom

  ⨯
• Maria Yazdanbakhsh,

  Affiliation Department of Parasitology, Leiden University Medical Centre, Leiden, The Netherlands

  ⨯
• William Harnett,

  Affiliation Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, United Kingdom

  ⨯
• Esther C. de Jong ,

  Contributed equally to this work with: Esther C. de Jong, William A. Paxton

  * E-mail: e.c.dejong@amc.uva.nl (ECdJ); w.a.paxton@liverpool.ac.uk (WAP)

  Affiliation Department of Cell Biology and Histology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands

  ⨯
• William A. Paxton

  Contributed equally to this work with: Esther C. de Jong, William A. Paxton

  * E-mail: e.c.dejong@amc.uva.nl (ECdJ); w.a.paxton@liverpool.ac.uk (WAP)

  Affiliations Laboratory of Experimental Virology, Department of Medical Microbiology, Centre for Infection and Immunity Amsterdam (CINIMA), Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands, Department of Clinical Infection, Microbiology and Immunology (CIMI), Institute of Infection and Global Health, University of Liverpool, Liverpool, United Kingdom

  ⨯